FXYD1 and cancer: Based on the obtained results (Figure 7), we hypothesize that, in the normal tissue, the lower level of cg23866403 loci methylation in the FXYD1 gene promoter results in a shortened spatial distance to the gene enhancer, and, as a result, FXYD1 increased expression compared to the cancer tissue.